as 11-12-2025 3:42pm EST
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
| Founded: | 1952 | Country: | United States |
| Employees: | N/A | City: | HERCULES |
| Market Cap: | 8.6B | IPO Year: | N/A |
| Target Price: | $358.50 | AVG Volume (30 days): | 251.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -24.56 | EPS Growth: | N/A |
| 52 Week Low/High: | $211.43 - $373.69 | Next Earning Date: | 10-29-2025 |
| Revenue: | $2,557,500,000 | Revenue Growth: | -0.88% |
| Revenue Growth (this year): | 1.89% | Revenue Growth (next year): | 2.45% |
BIO Breaking Stock News: Dive into BIO Ticker-Specific Updates for Smart Investing
Simply Wall St.
a month ago
Simply Wall St.
a month ago
GlobeNewswire
a month ago
Insider Monkey
2 months ago
Simply Wall St.
2 months ago
Insider Monkey
2 months ago
Zacks
2 months ago
Argus Research
5 months ago
The information presented on this page, "BIO Bio-Rad Laboratories Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.